New stent shows promise in Real-World heart patients
NCT ID NCT05677711
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 204 people with coronary artery disease who received the Ultimaster stent, a thin mesh tube coated with a drug that slowly releases to prevent arteries from clogging again. The stent's coating dissolves over 3-4 months. Researchers tracked safety and effectiveness over one year, looking at heart-related deaths, heart attacks, and the need for repeat procedures. The goal was to see how well the stent works in everyday practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ultimaster sirolimus-eluting coronary stent (a mesh tube coated with a drug that prevents artery re-blockage)
What this could lead to
If successful, this could confirm that the Ultimaster stent is a safe and effective option for treating blocked heart arteries in a wide range of patients.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. The stent still carries risks like blood clots or artery re-narrowing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yongin Severance Hospital
Yongin, Gyeonggi-do, 16995, South Korea